Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Argus Health
Farmers Insurance
AstraZeneca
Healthtrust
Medtronic
QuintilesIMS
Daiichi Sankyo

Generated: April 25, 2018

DrugPatentWatch Database Preview

PILOCARPINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Pilocarpine Hydrochloride, and when can generic versions of Pilocarpine Hydrochloride launch?

Pilocarpine Hydrochloride is a drug marketed by Akorn Inc, Impax Labs, Innogenix, Lannett, and Perrigo Pharma Intl. and is included in five NDAs.

The generic ingredient in PILOCARPINE HYDROCHLORIDE is pilocarpine hydrochloride. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the pilocarpine hydrochloride profile page.
Drug patent expirations by year for PILOCARPINE HYDROCHLORIDE
Pharmacology for PILOCARPINE HYDROCHLORIDE
Synonyms for PILOCARPINE HYDROCHLORIDE
(+)-Pilocarpine hydrochloride
(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone hydrochloride
(3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one hydrochloride
(3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]oxolan-2-one hydrochloride
(3S,4R)-3-ethyl-4-[(1-methylimidazol-5-yl)methyl]-3,4,5-trihydrofuran-2-one, c hloride
(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one hydrochloride
(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one;hydrochloride
(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one hydrochloride
(3S,4R)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone Hydrochloride
(3S,4R)-4,5-Dihydro-3-ethyl-4-(1-methyl-1H-imidazol-5-ylmethyl)-2(3H)-furanone hydrochloride
0WW6D218XJ
2(3H)-Furanone, 3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-, hydrochloride (1:1), (3S,4R)-
2(3H)-Furanone, 3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-, monohydrochloride, (3S-cis)-
2(3H)-Furanone, 3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-, monohydrochloride, (3S,4R)-
2(3H)-Furanone, monohydrochloride, (3S-cis)-
3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydro-2(3H)-furanone hydrochloride
54-71-7
5881AF
AC1L1LEC
AC1Q3EQS
Adsorbocarpine
AI3-61859
Akarpine
AKOS005267231
Almocarpine
Ami-pilo
Amistura P
AN-41661
ARONIS24309
BBC/465
BC245589
CCG-100757
CHEMBL1200330
component of Epicar
component of Pilocar
CPD000059053
CS-2973
D02200
DTXSID2041096
EINECS 200-212-5
EU-0100950
FT-0631237
HY-B0726
Isopto carpine
Isopto carpine (TN)
Isopto-carpine
KB-62493
KS-0000478G
LP00950
LS-109779
MFCD00012722
MI-Pilo Ophth Sol
Mistura P
MLS000069454
MLS000758210
MLS001076314
MLS001424017
MolPort-003-939-125
NC00007
NCGC00094254-01
NCGC00261635-01
NSC 5746
NSC-5746
NSC5746
Opera_ID_1616
P 6503
PILO
Pilocar
Pilocar SMP
Pilocarpal
Pilocarpin Hcl
Pilocarpine (Hydrochloride)
Pilocarpine HCl
Pilocarpine hydrochloride (JP17/USP)
Pilocarpine hydrochloride [USAN:JAN]
Pilocarpine hydrochloride [USP:JAN]
Pilocarpine hydrochloride, >=98% (titration), powder
Pilocarpine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Pilocarpine hydrochloride, meets USP testing specifications
Pilocarpine Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur
Pilocarpine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Pilocarpine hydrochlororide
Pilocarpine monohydrochloride
Pilocarpine muriate
pilocarpine-hcl
Pilocarpine, hydrochloride
PILOCARPINE, MONOHYDROCHLORIDE
Pilocel
Pilokarpin monohydrochloride
Pilomiotin
Pilopine
PILOPINE HS
Pilopine HS (TN)
Pilopine HS Gel
Pilovisc
regid855931
RNAICSBVACLLGM-GNAZCLTHSA-N
s4231
Salagen
SAM001246962
Sanpilo (TN)
SBB006456
SC-47863
SC-50867
SCHEMBL41427
SMR000059053
Sno pilo
Spersacarpine hydrochloride
SR-01000075339
SR-01000075339-1
ST057163
Tox21_500950
UNII-0WW6D218XJ
WLN: T5OVTJ C2 D1- DT5N CNJ C1 &GH

US Patents and Regulatory Information for PILOCARPINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc PILOCARPINE HYDROCHLORIDE pilocarpine hydrochloride SOLUTION;OPHTHALMIC 204398-001 Sep 27, 2017 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Innogenix PILOCARPINE HYDROCHLORIDE pilocarpine hydrochloride TABLET;ORAL 076963-002 Feb 27, 2007 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Impax Labs PILOCARPINE HYDROCHLORIDE pilocarpine hydrochloride TABLET;ORAL 077248-001 Mar 31, 2006 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lannett PILOCARPINE HYDROCHLORIDE pilocarpine hydrochloride TABLET;ORAL 077220-001 Oct 14, 2005 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Daiichi Sankyo
Chubb
AstraZeneca
Harvard Business School
US Department of Justice
Baxter
McKesson
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.